Acute respiratory tract infections: A potential trigger for the acute coronary syndrome

References

• The World Health Report 2004—annex table 2: Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2002. Geneva: World Health Organization; 2002. Available from: http://www.who.int/whr/2004/annex/en
   Google Scholar
• National Center of Health Statistics [database on the internet]. Atlanta (GA): Deaths and percentage of total deaths for the 10 leading causes of death: United States, 2002–2003. Available from: http://www.cdc.gov/nchs/data/hestat/leadingdeaths03_tables.pdf#1
   Google Scholar
• Fox K. A. Management of acute coronary syndromes: an update. Heart 2004; 90: 698–706
   PubMed Web of Science ®Google Scholar
• Grech E. D., Ramsdale D. R. Acute coronary syndrome: unstable angina and non‐ST segment elevation myocardial infarction. BMJ 2003; 326: 1259–61
   PubMedGoogle Scholar
• Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Virmani R., Kolodgie F. D., Burke A. P., Farb A., Schwartz S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262–75
   PubMed Web of Science ®Google Scholar
• Spodick D. H. Inflammation and the onset of myocardial infarction. Ann Intern Med 1985; 102: 699–702
   PubMed Web of Science ®Google Scholar
• Valtonen V. V. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 23: 539–43
   PubMed Web of Science ®Google Scholar
• Nieminen M. S., Mattila K., Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993; 14: 12–16
   PubMed Web of Science ®Google Scholar
• Meier C. R., Jick S. S., Derby L. E., Vasilakis C., Jick H. Acute respiratory‐tract infections and risk of first‐time acute myocardial infarction. Lancet 1998; 351: 1467–71
   PubMed Web of Science ®Google Scholar
• Smeeth L., Thomas S. L., Hall A. J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611–8
   PubMed Web of Science ®Google Scholar
• Epstein S. E., Zhou Y. F., Zhu J. Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation 1999; 110: e20–8
   Google Scholar
• Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095–103
   PubMed Web of Science ®Google Scholar
• Madjid M., Aboshady I., Awan I., Litovsky S., Casscells S. W. Influenza and cardiovascular disease: is there a causal relationship?. Tex Heart Inst J 2004; 31: 4–13
   PubMed Web of Science ®Google Scholar
• Madjid M., Naghavi M., Litovsky S., Casscells S. W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730–6
   PubMed Web of Science ®Google Scholar
• Van Lentsen B. J., Wagner A. C., Anantharamaiah G. M., Garber D. W., Fishbein M. C., Adhikary L., et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D‐4F, an apolipoprotein A‐I mimetic peptide. Circulation 2002; 106: 1127–32
   Google Scholar
• Van Lenten B. J., Wagner A. C., Nayak D. P., Hama S., Navab M., Fogelman A. M. High‐density lipoprotein loses its anti‐inflammatory properties during acute influenza A infection. Circulation 2001; 103: 2283–8
   PubMed Web of Science ®Google Scholar
• Pesonen E., Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101: 512–3
   PubMedGoogle Scholar
• Abinader E. G., Sharif D. S., Omary M. Inferior wall myocardial infarction preceded by acute exudative pharyngitis in young males. Isr J Med Sci 1993; 29: 764–9
   Google Scholar
• Bourne G., Wedgwood J. Heart‐disease and influenza. Lancet 1959; 1: 1226–8
   Google Scholar
• Penttinen J., Valonen P. The risk of myocardial infarction among Finnish farmers seeking medical care for an infection. Am J Public Health 1996; 86: 1440–2
   Google Scholar
• Zheng Z. J., Mittleman M. A., Tofler G. H., Pomeroy C., Dampier C., Wides B., et al. Infections prior to acute myocardial infarction onset. J Am Coll Cardiol 1998; 31: 132A
   Google Scholar
• Spencer F. A., Goldberg R. J., Becker R. C., Gore J. M. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1226–33
   PubMed Web of Science ®Google Scholar
• Glezen W. P., Payne A. A., Snyder D. N., Downs T. D. Mortality and influenza. J Infect Dis 1982; 146: 313–21
   PubMed Web of Science ®Google Scholar
• Tillett H. E., Smith J. W., Gooch C. D. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983; 12: 344–52
   PubMed Web of Science ®Google Scholar
• Scragg R. Effect of influenza epidemics on Australian mortality. Med J Aust 1985; 142: 98–102
   Google Scholar
• Marshall R. J., Scragg R., Bourke P. An analysis of the seasonal variation of coronary heart disease and respiratory disease mortality in New Zealand. Int J Epidemiol 1988; 17: 325–31
   PubMed Web of Science ®Google Scholar
• Spodick D. H., Flessas A. P., Johnson M. M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481–2
   PubMed Web of Science ®Google Scholar
• Mattila K. J. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989; 225: 293–6
   PubMed Web of Science ®Google Scholar
• Cox N. J., Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000; 51: 407–21
   PubMed Web of Science ®Google Scholar
• Collins S. D. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep 1932; 47: 2159–80
   PubMedGoogle Scholar
• Musher D. M., Rueda A. M., Kaka A. S., Mapara S. M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007:15; 45: 158–65
   PubMed Web of Science ®Google Scholar
• Fabricant C. G., Fabricant J., Litrenta M. M., Minick C. R. Virus‐induced atherosclerosis. J Exp Med 1978; 148: 335–40
   PubMed Web of Science ®Google Scholar
• Hajjar D. P., Pomerantz K. B., Falcone D. J., Weksler B. B., Grant A. J. Herpes Simplex virus infection in human arterial cells: implications in arteriosclerosis. J Clin Invest 1987; 80: 1317–21
   Google Scholar
• Dvorakova A., Poledne R. Influenza—a trigger for acute myocardial infarction. Atherosclerosis 2004; 172: 391
   Google Scholar
• Madjid M., Vela D., Khalili‐Tabrizi H., Casscells S. W., Litovsky S. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 2007; 34: 11–18
   PubMed Web of Science ®Google Scholar
• Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039–45
   PubMed Web of Science ®Google Scholar
• Siscovick D. S., Raghunathan T. E., Lin D., Weinmann S., Arbogast P., Lemaitre R. N., et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674–7
   PubMed Web of Science ®Google Scholar
• Nichol K. L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322–32
   PubMed Web of Science ®Google Scholar
• Gurfinkel E. P., Leon de la Fuente R., Mendiz O., Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004; 25: 25–31
   PubMed Web of Science ®Google Scholar
• Heffelfinger J. D., Heckbert S. R., Psaty B. M., Weiss N. S., Thompson W. W., Bridges C. B., et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006; 2: 161–6
   PubMed Web of Science ®Google Scholar
• Christenson B., Lundbergh P., Hedlund J., Ortqvist A. Effects of a large‐scale intervention with influenza and 23‐valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357: 1008–11
   PubMed Web of Science ®Google Scholar
• Vila‐Corcoles A., Ochoa‐Gondar O., Llor C., Hospital I., Rodriguez T., Gomez A. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J 2005; 26: 1086–91
   PubMed Web of Science ®Google Scholar
• Jackson L. A., Neuzil K. M., Yu O., Benson P., Barlow W. E., Adams A. L., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747–55
   PubMed Web of Science ®Google Scholar
• Bruschke A. V., Kramer J. R., Bal E. T., Haque I. U., Detrano R. C., Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J 1989; 117: 296–305
   Google Scholar
• Davies M. J., Woolf N., Rowles P. M., Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988; 60: 459
   PubMedGoogle Scholar
• Kockx M. M., De Meyer G. R., Muhring J., Jacob W., Bult H., Herman A. G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97: 2307
   PubMed Web of Science ®Google Scholar
• Paoletti R., Gotto A. M Jr., Hajjar D. P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 109: III20
   PubMed Web of Science ®Google Scholar
• Libby P., Ridker P. M., Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135
   PubMed Web of Science ®Google Scholar
• Alexander R. W. The coronary ischemic syndromes: relationship to the biology of atherosclerosis. Hurst's the heart: arteries and veins, 8th ed, R. C Schlant, R. W Alexander. McGraw‐Hill, New York 1994; 1021–31
   Google Scholar
• Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002; 110: 905
   PubMed Web of Science ®Google Scholar
• Anderson T. J., Meredith I. T., Charbonneau F., Yeung A. C., Frei B., Selwyn A. P., et al. Endothelium‐dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93: 1647
   PubMedGoogle Scholar
• Clarkson P., Celermajer D. S., Powe A. J., Donald A. E., Henry R. M., Deanfield J. E. Endothelium‐dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997; 96: 3378
   PubMed Web of Science ®Google Scholar
• Mäkimattila S., Mäntysaari M., Groop P. H., Summanen P., Virkamäki A., Schlenzka A., et al. Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin‐dependent diabetes mellitus. Circulation 1997; 95: 618
   Google Scholar
• Barger A. C., Beeuwkes R., Lainey L. L., Silverman K. J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310: 175
   PubMed Web of Science ®Google Scholar
• Virmani R., Narula J., Farb A. When neoangiogenesis ricochets. Am Heart J 1998; 136: 937
   Google Scholar
• Keller T. T., Mairuhu A. T., de Kruif M. D., Klein S. K., Gerdes V. E., ten Cate H., et al. Infections and endothelial cells. Cardiovasc Res 2003; 60: 40–8
   PubMed Web of Science ®Google Scholar
• Levi M., van der Poll T., Büller H. R. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109: 2698–704
   PubMed Web of Science ®Google Scholar
• Burke A. P., Kolodgie F. D., Farb A., Weber D. K., Malcom G. T., Smialek J., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103: 934
   PubMed Web of Science ®Google Scholar
• van der Wal A. C., Becker A. E., van der Loos C. M., Das P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36–44
   PubMed Web of Science ®Google Scholar
• Kol A., Libby P. Molecular mediators of arterial inflammation: a role for microbial products?. Am Heart J 1999; 138: S450–2
   Google Scholar
• Ludewig B., Krebs P., Scandella E. Immunopathogenesis of atherosclerosis. J Leukoc Biol 2004; 76: 300–6
   Google Scholar
• Espinola‐Klein C., Rupprecht H. J., Blankenberg S., Bickel C., Kopp H., et al. Impact of pathogen burden on extent and long‐term prognosis of atherosclerosis. Circulation 2002; 105: 15–21
   PubMed Web of Science ®Google Scholar
• Epstein S. E., Zhu J., Burnett M. S., Zhou Y. F., Vercellotti G., Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20: 1417–20
   PubMed Web of Science ®Google Scholar
• Huittinen T., Leinonen M., Tenkanen L., Virkkunen H., Manttari M., Palosuo T., et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003; 107: 2566–70
   Google Scholar
• Chiu B., Viira E., Tucker W., Fong I. W. Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144–8
   PubMed Web of Science ®Google Scholar
• Georges J. L., Rupprecht H. J., Blankenberg S., Priorier O., Bickel C., Hafner G., et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 2003; 92: 515–21
   Google Scholar
• Naghavi M., Wyde P., Litovsky S., Madjid M., Akhtar A., Naguib S., et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E‐deficient mice. Circulation 2003; 107: 762–8
   PubMed Web of Science ®Google Scholar
• Li L., Messas E., Batista E. L Jr., Levine R. A., Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E‐deficient murine model. Circulation 2002; 105: 861–7
   PubMed Web of Science ®Google Scholar
• Davies M. J. The composition of coronary‐artery plaques. N Engl J Med 1997; 336: 1312–4
   PubMed Web of Science ®Google Scholar
• Falk E., Shah P. K., Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71
   PubMed Web of Science ®Google Scholar
• Petrakopoulou P., Kübrich M., Pehlivanli S., Meiser B., Reichart B., von Scheidt W., et al. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 2004; 110: II207–12
   Google Scholar
• Liuba P., Pesonen E., Paakkari I., Batra S., Forslid A., Kovanen P., et al. Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs. Atherosclerosis 2003; 167: 215–22
   PubMedGoogle Scholar
• Lundman P., Eriksson M., Schenck‐Gustafsson K., Karpe F., Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266–8
   PubMed Web of Science ®Google Scholar
• Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., et al. Hyperglycemia rapidly suppresses flow‐mediated endothelium‐dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146–54
   PubMed Web of Science ®Google Scholar
• Colden‐Stanfield M., Ratcliffe D., Cramer E. B., Gallin E. K. Characterization of influenza virus‐induced leukocyte adherence to human umbilical vein endothelial cell monolayers. J Immunol 1993; 151: 310–21
   PubMed Web of Science ®Google Scholar
• Etingin O. R., Silverstein R. L., Friedman H. M., Hajjar D. P. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 1990; 61: 657–62
   Google Scholar
• Herzberg M. C., Meyer M. W. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol 1996; 67: 1138–42
   PubMed Web of Science ®Google Scholar
• Koenig W., Sund M., Filipiak B., Döring A., Löwel H., Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA‐Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998; 18: 768–72
   PubMed Web of Science ®Google Scholar
• Conti C. R. Vascular events responsible for thrombotic occlusion of a blood vessel. Clin Cardiol 1993; 16: 761–2
   Google Scholar
• Knox S. S., Siegmund K. D., Weidner G., Ellison R. C., Adelman A., Paton C. Hostility, social support, and coronary heart disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Cardiol 1998; 82: 1192–6
   PubMed Web of Science ®Google Scholar
• Levi M., Keller T. T., van Gorp E., ten Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60: 26–39
   PubMed Web of Science ®Google Scholar
• Zimmerman G. A., McIntyre T. M., Prescott S. M., Stafforini D. M. The platelet‐activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30: S294–301
   PubMed Web of Science ®Google Scholar
• Visseren F. L., Bouwman J. J., Bouter K. P., Diepersloot R. J., Groot P. H de., Erkelens D. W. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000; 84: 319–24
   PubMed Web of Science ®Google Scholar
• Bouwman J. J., Visseren F. L., Bosch M. C., Bouter K. P., Diepersloot R. J. Procoagulant and inflammatory response of virus‐infected monocytes. Eur J Clin Invest 2002; 32: 759–66
   PubMed Web of Science ®Google Scholar
• van der Poll T., de Jonge E., Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 639–51
   PubMed Web of Science ®Google Scholar
• Coughlin S. R. Thrombin signaling and protease‐activated receptors. Nature 2000; 407: 258–64
   PubMed Web of Science ®Google Scholar
• Shaw P. X. Rethinking oxidized low‐density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz) 2004; 52: 225–39
   PubMed Web of Science ®Google Scholar
• Ludewig B., Laman J. D. The in and out of monocytes in atherosclerotic plaques: balancing inflammation through migration. Proc Natl Acad Sci U S A 2004; 101: 11529–30
   Google Scholar
• van Lenten B. J., Wagner A. C., Navab M., Anantharamaiah G. M., Hui E. K., Nayak D. P., et al. D‐4F, an apolipoprotein A‐I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 2004; 110: 3252–8
   PubMed Web of Science ®Google Scholar
• Stone A. F., Mendall M. A., Kaski J. C., Edger T. M., Risley P., Polonieki J., et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002; 106: 1219–23
   PubMed Web of Science ®Google Scholar
• Sinisalo j., Mattila K., Valtonen V., Anttonen O., Juvonen J., Melin J., et al. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non‐q‐wave coronary syndrome. Circulation 2002; 105: 1555–60
   PubMed Web of Science ®Google Scholar
• Cercek B., Shah P. K., Noc M., Zahger D., Zeymer U., Matetzky S., et al. Effect of short‐term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003; 361: 809–13
   PubMed Web of Science ®Google Scholar
• Cannon C. P., Braunwald E., McCabe C. H., Grayston J. T., Muhlestein B., Giugliano R. P., et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005; 352: 1646–54
   PubMed Web of Science ®Google Scholar
• Madjid M., Casscells S. W. Of birds and men: cardiologists' role in influenza pandemics. Lancet 2004; 364: 1309
   Google Scholar
• Madjid M., Miller C., Zarubaev V. V., Marinich I. G., Kiselev O. I., Lobzin Y. V., et al. Influenza epidemics are associated with a surge in autopsy‐confirmed coronary artery disease death: results from eight years of autopsies in 34,892 subjects. Eur Heart J 2007; 28: 1205–10
   PubMed Web of Science ®Google Scholar